AmMax Bio Names Biopharmaceutical Executive Travis Read as President and Chief Operating Officer

REDWOOD CITY, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- AmMax Bio, Inc. ("AmMax”), a private clinical-stage biopharmaceutical company focused on the development of first and best-in-class ADCs for cancer patients, today announced the appointment of Travis Read as President and Chief Operating Officer. Read joins AmMax to help guide the company through a transformational period of clinical and operational growth, bringing nearly two decades of experience in biopharmaceutical company building, ope